logo
ResearchBunny Logo
Safety and efficacy of four-segmented Rift Valley fever virus in young sheep, goats and cattle

Veterinary Science

Safety and efficacy of four-segmented Rift Valley fever virus in young sheep, goats and cattle

P. J. W. Schreur, N. Oreshkova, et al.

Discover groundbreaking research on Rift Valley fever virus (RVFV), where the developed RVFV-4s vaccine candidate is shown to be completely avirulent and induces protective immunity in various animals. This essential study was conducted by leading experts including Paul J. Wichgers Schreur and Nadia Oreshkova.

00:00
Playback language: English
Abstract
Rift Valley fever virus (RVFV) is a mosquito-borne bunyavirus causing severe outbreaks. A four-segmented RVFV (RVFV-4s) vaccine candidate (vRVFV-4s) was developed and shown to be completely avirulent in previous studies. This study demonstrates that vRVFV-4s does not disseminate in vaccinated animals, is not shed, does not revert to virulence, and induces protective immunity against homologous and heterologous RVFV challenge in lambs, goats, and calves after a single vaccination.
Publisher
npj Vaccines
Published On
Jul 24, 2020
Authors
Paul J. Wichgers Schreur, Nadia Oreshkova, Lucien van Keulen, Jet Kant, Sandra van de Water, Pál Soós, Yves Dehon, Anna Kollár, Zoltán Pénzes, Jeroen Kortekaas
Tags
Rift Valley fever virus
Vaccine
Avirulent
Immunity
Veterinary
Listen, Learn & Level Up
Over 10,000 hours of research content in 25+ fields, available in 12+ languages.
No more digging through PDFs, just hit play and absorb the world's latest research in your language, on your time.
listen to research audio papers with researchbunny